Literature DB >> 35112782

Risk of new-onset type 2 diabetes in 600 055 people after COVID-19: A cohort study.

Morgan Birabaharan1, David C Kaelber2, Jeremy H Pettus3, Davey M Smith1.   

Abstract

Entities:  

Keywords:  cohort study; database research; health economics; population study; primary care; type 2 diabetes

Mesh：

Year:  2022        PMID： 35112782      PMCID： PMC9035030          DOI： 10.1111/dom.14659

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN： 1462-8902            Impact factor:   6.408


× No keyword cloud information.
  13 in total

1.  Preserved C-peptide in survivors of COVID-19: Post hoc analysis.

Authors:  Sophie A Clarke; Maria Phylactou; Bijal Patel; Edouard G Mills; Beatrice Muzi; Chioma Izzi-Engbeaya; Bernard Khoo; Karim Meeran; Alexander N Comninos; Ali Abbara; Tricia Tan; Nick Oliver; Waljit S Dhillo
Journal:  Diabetes Obes Metab       Date:  2021-12-15       Impact factor: 6.577

2.  Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data.

Authors:  Donald R Miller; Monika M Safford; Leonard M Pogach
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

3.  Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection.

Authors:  Laura Montefusco; Moufida Ben Nasr; Francesca D'Addio; Cristian Loretelli; Antonio Rossi; Ida Pastore; Giuseppe Daniele; Ahmed Abdelsalam; Anna Maestroni; Marco Dell'Acqua; Elio Ippolito; Emma Assi; Vera Usuelli; Andy Joe Seelam; Roberta Maria Fiorina; Enrica Chebat; Paola Morpurgo; Maria Elena Lunati; Andrea Mario Bolla; Giovanna Finzi; Reza Abdi; Joseph V Bonventre; Stefano Rusconi; Agostino Riva; Domenico Corradi; Pierachille Santus; Manuela Nebuloni; Franco Folli; Gian Vincenzo Zuccotti; Massimo Galli; Paolo Fiorina
Journal:  Nat Metab       Date:  2021-05-25

4.  SARS-CoV-2 Receptor Angiotensin I-Converting Enzyme Type 2 (ACE2) Is Expressed in Human Pancreatic β-Cells and in the Human Pancreas Microvasculature.

Authors:  Daniela Fignani; Giada Licata; Noemi Brusco; Laura Nigi; Giuseppina E Grieco; Lorella Marselli; Lut Overbergh; Conny Gysemans; Maikel L Colli; Piero Marchetti; Chantal Mathieu; Decio L Eizirik; Guido Sebastiani; Francesco Dotta
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-13       Impact factor: 5.555

5.  Viral infiltration of pancreatic islets in patients with COVID-19.

Authors:  Charlotte Steenblock; Stefanie Richter; Ilona Berger; Marko Barovic; Janine Schmid; Undine Schubert; Natalia Jarzebska; Anne von Mässenhausen; Andreas Linkermann; Annette Schürmann; Jessica Pablik; Thomas Dienemann; Katja Evert; Roman N Rodionov; Natalia Y Semenova; Vsevolod A Zinserling; Raul R Gainetdinov; Gustavo Baretton; Dirk Lindemann; Michele Solimena; Barbara Ludwig; Stefan R Bornstein
Journal:  Nat Commun       Date:  2021-06-10       Impact factor: 14.919

6.  Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study.

Authors:  Sufei Wang; Pei Ma; Shujing Zhang; Siwei Song; Zhihui Wang; Yanling Ma; Juanjuan Xu; Feng Wu; Limin Duan; Zhengrong Yin; Huilin Luo; Nian Xiong; Man Xu; Tianshu Zeng; Yang Jin
Journal:  Diabetologia       Date:  2020-07-10       Impact factor: 10.122

7.  Diabetes, obesity and COVID-19: A complex interplay.

Authors:  Prashanth Vas; David Hopkins; Michael Feher; Francesco Rubino; Martin B Whyte
Journal:  Diabetes Obes Metab       Date:  2020-07-28       Impact factor: 6.408

8.  Proportion of newly diagnosed diabetes in COVID-19 patients: A systematic review and meta-analysis.

Authors:  Thirunavukkarasu Sathish; Nitin Kapoor; Yingting Cao; Robyn J Tapp; Paul Zimmet
Journal:  Diabetes Obes Metab       Date:  2020-12-29       Impact factor: 6.408

9.  Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID-19.

Authors:  Huiqing Li; Shenghua Tian; Ting Chen; Zhenhai Cui; Ningjie Shi; Xueyu Zhong; Kangli Qiu; Jiaoyue Zhang; Tianshu Zeng; Lulu Chen; Juan Zheng
Journal:  Diabetes Obes Metab       Date:  2020-06-30       Impact factor: 6.408
View more
  3 in total

1.  Risk of incident diabetes post-COVID-19: A systematic review and meta-analysis.

Authors:  Mainak Banerjee; Rimesh Pal; Sulagna Dutta
Journal:  Prim Care Diabetes       Date:  2022-05-30       Impact factor: 2.567

Review 2.  Diabetes and COVID-19: Short- and Long-Term Consequences.

Authors:  Charlotte Steenblock; Mohamed Hassanein; Emran G Khan; Mohamad Yaman; Margrit Kamel; Mahmoud Barbir; Dietrich E Lorke; John A Rock; Dean Everett; Saqipi Bejtullah; Adrian Heimerer; Ermal Tahirukaj; Petrit Beqiri; Stefan R Bornstein
Journal:  Horm Metab Res       Date:  2022-06-20       Impact factor: 2.788

3.  Canakinumab in patients with COVID-19 and type 2 diabetes - A multicentre, randomised, double-blind, placebo-controlled trial.

Authors:  Matthias Hepprich; Jonathan M Mudry; Claudia Gregoriano; Francois R Jornayvaz; Sebastian Carballo; Anne Wojtusciszyn; Pierre-Alexandre Bart; Jean-Daniel Chiche; Stefan Fischli; Thomas Baumgartner; Claudia Cavelti-Weder; Dominique L Braun; Huldrych F Günthard; Felix Beuschlein; Anna Conen; Emily West; Egon Isenring; Stefan Zechmann; Gabriela Bucklar; Yoann Aubry; Ludovic Dey; Beat Müller; Patrick Hunziker; Philipp Schütz; Marco Cattaneo; Marc Y Donath
Journal:  EClinicalMedicine       Date:  2022-09-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.